|
Class
|
Product Group
|
Product
|
Species
|
Description
|
Raybiotech Catalog
|
Size
|
List Price
|
|
Peptide
|
Synthetic peptide
|
C-telopeptide
|
|
MF: C34H56N14O13, MW: 868.91(H-Glu-Lys-Ala-His-Asp-Gly-Gly-Arg-OH)
|
CG55264
|
2.5 mg
|
160.00
|
|
Peptide
|
Synthetic peptide
|
C-telopeptide
|
|
MF: C34H56N14O13, MW: 868.91(H-Glu-Lys-Ala-His-Asp-Gly-Gly-Arg-OH)
|
CG55264
|
0.5 mg
|
90.00
|
|
Peptide
|
Synthetic peptide
|
C-telopeptide
|
|
MF: C34H56N14O13, MW: 868.91(H-Glu-Lys-Ala-His-Asp-Gly-Gly-Arg-OH)
|
CG55264
|
1 mg
|
110.00
|
|
Peptide
|
Synthetic peptide
|
CTX IV (3-14) [Arg3,14]
|
|
MF: C74H119N25O14, MW: 1582.91(H-Arg-Asn-Arg-Leu-Ile-Pro-Pro-Phe-Trp-Lys-Thr-Arg-NH2)
|
CG52237
|
2 mg
|
140.00
|
|
Peptide
|
Synthetic peptide
|
CTX IV (3-14) [Arg3,14]
|
|
MF: C74H119N25O14, MW: 1582.91(H-Arg-Asn-Arg-Leu-Ile-Pro-Pro-Phe-Trp-Lys-Thr-Arg-NH2)
|
CG52237
|
5 mg
|
210.00
|
|
Peptide
|
Synthetic peptide
|
CTX IV (3-14) [Arg3,14]
|
|
MF: C74H119N25O14, MW: 1582.91(H-Arg-Asn-Arg-Leu-Ile-Pro-Pro-Phe-Trp-Lys-Thr-Arg-NH2)
|
CG52237
|
1 mg
|
120.00
|
|
Peptide
|
Synthetic peptide
|
CTX IV (6-12)
|
|
MF: C48H70N10O7, MW: 899.14(H-Leu-Ile-Pro-Pro-Phe-Trp-Lys-NH2)
|
CG52236
|
5 mg
|
160.00
|
|
Peptide
|
Synthetic peptide
|
CTX IV (6-12)
|
|
MF: C48H70N10O7, MW: 899.14(H-Leu-Ile-Pro-Pro-Phe-Trp-Lys-NH2)
|
CG52236
|
1 mg
|
90.00
|
|
Peptide
|
Synthetic peptide
|
CTX IV (6-12)
|
|
MF: C48H70N10O7, MW: 899.14(H-Leu-Ile-Pro-Pro-Phe-Trp-Lys-NH2)
|
CG52236
|
2 mg
|
110.00
|
|
Peptide
|
Synthetic peptide
|
C-Type Natriuretic Peptide
|
chicken
|
MF: C93H157N29O29S3, MW: 2241.66(H-Gly-Leu-Ser-Arg-Ser-Cys-Phe-Gly-Val-Lys-Leu-Asp-Arg-
Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys-OH(Cys6-Cys22)) |
CG55271
|
0.5 mg
|
130.00
|
|
Peptide
|
Synthetic peptide
|
C-Type Natriuretic Peptide
|
chicken
|
MF: C93H157N29O29S3, MW: 2241.66(H-Gly-Leu-Ser-Arg-Ser-Cys-Phe-Gly-Val-Lys-Leu-Asp-Arg-
Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys-OH(Cys6-Cys22)) |
CG55271
|
1 mg
|
180.00
|
|
Peptide
|
Synthetic peptide
|
C-Type Natriuretic Peptide
|
chicken
|
MF: C93H157N29O29S3, MW: 2241.66(H-Gly-Leu-Ser-Arg-Ser-Cys-Phe-Gly-Val-Lys-Leu-Asp-Arg-
Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys-OH(Cys6-Cys22)) |
CG55271
|
2.5 mg
|
270.00
|
|
Peptide
|
Synthetic peptide
|
C-Type Natriuretic Peptide (1-22)
|
human
|
MF: C93H157N27O28S3, MW:
2197.64(H-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys-OH(Cys6-Cys22))
|
CG52233
|
1 mg
|
200.00
|
|
Peptide
|
Synthetic peptide
|
C-Type Natriuretic Peptide (1-22)
|
human
|
MF: C93H157N27O28S3, MW:
2197.64(H-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys-OH(Cys6-Cys22))
|
CG52233
|
2.5 mg
|
300.00
|
|
Peptide
|
Synthetic peptide
|
C-Type Natriuretic Peptide (1-22)
|
human
|
MF: C93H157N27O28S3, MW:
2197.64(H-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys-OH(Cys6-Cys22))
|
CG52233
|
0.5 mg
|
140.00
|
|
Peptide
|
Synthetic peptide
|
DAGO
|
|
MF: C26H35N5O6, MW: 513(H-Tyr-D-Ala-Gly-N-Me-Phe-Gly-OL)
|
CG55194
|
5 mg
|
120.00
|
|
Peptide
|
Synthetic peptide
|
D-Ala-D-Ala
|
|
MF: C6H12N2O3, MW: 160.17(D-Ala-D-Ala-OH) |
CG51527
|
250 mg
|
95.00
|
|
Peptide
|
Synthetic peptide
|
Dansyl-Y-V-G
|
|
MF: C28H34N4O7S1, MW: 571.63(Dansyl-Tyr-Val-Gly) |
CG51628
|
50 mg
|
210.00
|
|
Peptide
|
Synthetic peptide
|
Dansyl-Y-V-G
|
|
MF: C28H34N4O7S1, MW: 571.63(Dansyl-Tyr-Val-Gly) |
CG51628
|
125 mg
|
340.00
|
|
Peptide
|
Synthetic peptide
|
Dansyl-Y-V-G
|
|
MF: C28H34N4O7S1, MW: 571.63(Dansyl-Tyr-Val-Gly) |
CG51628
|
25 mg
|
150.00
|
|
Peptide
|
Synthetic peptide
|
D-D-D-D-D
|
|
MF: C20H27N5O16, MW: 593.46(H-Asp-Asp-Asp-Asp-Asp-OH) |
CG55184
|
1 mg
|
90.00
|
|
Peptide
|
Synthetic peptide
|
D-D-D-D-D
|
|
MF: C20H27N5O16, MW: 593.46(H-Asp-Asp-Asp-Asp-Asp-OH) |
CG55184
|
2 mg
|
110.00
|
|
Peptide
|
Synthetic peptide
|
D-D-D-D-D
|
|
MF: C20H27N5O16, MW: 593.46(H-Asp-Asp-Asp-Asp-Asp-OH) |
CG55184
|
5 mg
|
160.00
|
|
Peptide
|
Synthetic peptide
|
D-D-D-D-D-D
|
|
MF: C24H32N6O19, MW: 708.55(H-Asp-Asp-Asp-Asp-Asp-Asp-OH)
|
CG55198
|
1 mg
|
90.00
|
|
Peptide
|
Synthetic peptide
|
D-D-D-D-D-D
|
|
MF: C24H32N6O19, MW: 708.55(H-Asp-Asp-Asp-Asp-Asp-Asp-OH)
|
CG55198
|
2 mg
|
110.00
|
|
Peptide
|
Synthetic peptide
|
D-D-D-D-D-D
|
|
MF: C24H32N6O19, MW: 708.55(H-Asp-Asp-Asp-Asp-Asp-Asp-OH)
|
CG55198
|
5 mg
|
160.00
|
|
Peptide
|
Synthetic peptide
|
Delta Sleep Inducing Peptide
|
|
MF: C35H48N10O15, MW: 848.83(H-Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu-OH)
|
CG55319
|
5 mg
|
120.00
|
|
Peptide
|
Synthetic peptide
|
Deltorphin 1
|
|
MF: C37H52N8O10, MW: 768.87(Tyr-D-Ala-Phe-Asp-Val-Val-Gly-NH2)
|
CG50601
|
5 mg
|
140.00
|
|
Peptide
|
Synthetic peptide
|
Deltorphin 1
|
|
MF: C37H52N8O10, MW: 768.87(Tyr-D-Ala-Phe-Asp-Val-Val-Gly-NH2)
|
CG50601
|
10 mg
|
200.00
|
|
Peptide
|
Synthetic peptide
|
Deltorphin 1
|
|
MF: C37H52N8O10, MW: 768.87(Tyr-D-Ala-Phe-Asp-Val-Val-Gly-NH2)
|
CG50601
|
25 mg
|
300.00
|
|
Peptide
|
Synthetic peptide
|
Dermaseptin ?
|
|
MF: C152H257N43O44S2, MW:
3455.08(Ala-Leu-Trp-Lys-Thr-Met-Leu-Lys-Lys-Leu-Gly-Thr-Met-Ala-Leu-His-Ala-Gly-Lys-Ala-Leu-Gly-Ala-Ala-Ala-Ala-Asp-Thr-Ile-Ser-Gln-Gly-Thr-Gln)
|
CG52239
|
0.5 mg
|
130.00
|
|
Peptide
|
Synthetic peptide
|
Dermaseptin ?
|
|
MF: C152H257N43O44S2, MW:
3455.08(Ala-Leu-Trp-Lys-Thr-Met-Leu-Lys-Lys-Leu-Gly-Thr-Met-Ala-Leu-His-Ala-Gly-Lys-Ala-Leu-Gly-Ala-Ala-Ala-Ala-Asp-Thr-Ile-Ser-Gln-Gly-Thr-Gln)
|
CG52239
|
1 mg
|
180.00
|
|
Peptide
|
Synthetic peptide
|
Dermaseptin ?
|
|
MF: C152H257N43O44S2, MW:
3455.08(Ala-Leu-Trp-Lys-Thr-Met-Leu-Lys-Lys-Leu-Gly-Thr-Met-Ala-Leu-His-Ala-Gly-Lys-Ala-Leu-Gly-Ala-Ala-Ala-Ala-Asp-Thr-Ile-Ser-Gln-Gly-Thr-Gln)
|
CG52239
|
2.5 mg
|
270.00
|
|
Peptide
|
Synthetic peptide
|
Dermenkephalin
|
|
MF: C44H62N10O10S2, MW: 955.17(H-Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2)
|
CG55315
|
5 mg
|
120.00
|
|
Peptide
|
Synthetic peptide
|
Dermorphin
|
|
MF: C40H50N8O10, MW: 802.88(Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2)
|
CG52238
|
25 mg
|
300.00
|
|
Peptide
|
Synthetic peptide
|
Dermorphin
|
|
MF: C40H50N8O10, MW: 802.88(Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2)
|
CG52238
|
5 mg
|
140.00
|
|
Peptide
|
Synthetic peptide
|
Dermorphin
|
|
MF: C40H50N8O10, MW: 802.88(Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2)
|
CG52238
|
10 mg
|
200.00
|
|
Peptide
|
Synthetic peptide
|
Dermorphin Analog
|
|
MF: C44H59NllO10, MW: 902.03(H-Tyr-D-Arg-Phe-Sar-Tyr-Pro-Ser-NH2)
|
CG55308
|
25 mg
|
120.00
|
|
Peptide
|
Synthetic peptide
|
Desmopressin
|
|
MF: C46H64N14O12S2, MW: 1069.1(Map-Tyr-Phe-Gln-Asn-Cys-Pro-D-Arg-Gly-NH2(Disulfide
bridge, Map1-Cys6)) |
CG52240
|
2 mg
|
140.00
|
|
Peptide
|
Synthetic peptide
|
Desmopressin
|
|
MF: C46H64N14O12S2, MW: 1069.1(Map-Tyr-Phe-Gln-Asn-Cys-Pro-D-Arg-Gly-NH2(Disulfide
bridge, Map1-Cys6)) |
CG52240
|
1 mg
|
120.00
|
|
Peptide
|
Synthetic peptide
|
Desmopressin
|
|
MF: C46H64N14O12S2, MW: 1069.1(Map-Tyr-Phe-Gln-Asn-Cys-Pro-D-Arg-Gly-NH2(Disulfide
bridge, Map1-Cys6)) |
CG52240
|
5 mg
|
210.00
|
|
Peptide
|
Synthetic peptide
|
Egg Laying Hormone of Aplysia
|
|
MF: C190H329N59O57S1, MW:
4384.17(H-Ile-Ser-Ile-Asn-Gln-Asp-Leu-Lys-Ala-Ile-Thr-Asp-Met-Leu-Leu-Thr-Glu-Gln-Ile-Arg-Glu-Arg-Gln-Arg-Tyr-Leu-Ala-Asp-Leu-Arg-Gln-Arg-Leu-Leu-Glu-Lys-NH2)
|
CG55299
|
0.5 mg
|
140.00
|
|
Peptide
|
Synthetic peptide
|
Egg Laying Hormone of Aplysia
|
|
MF: C190H329N59O57S1, MW:
4384.17(H-Ile-Ser-Ile-Asn-Gln-Asp-Leu-Lys-Ala-Ile-Thr-Asp-Met-Leu-Leu-Thr-Glu-Gln-Ile-Arg-Glu-Arg-Gln-Arg-Tyr-Leu-Ala-Asp-Leu-Arg-Gln-Arg-Leu-Leu-Glu-Lys-NH2)
|
CG55299
|
1 mg
|
200.00
|
|
Peptide
|
Synthetic peptide
|
Egg Laying Hormone of Aplysia
|
|
MF: C190H329N59O57S1, MW:
4384.17(H-Ile-Ser-Ile-Asn-Gln-Asp-Leu-Lys-Ala-Ile-Thr-Asp-Met-Leu-Leu-Thr-Glu-Gln-Ile-Arg-Glu-Arg-Gln-Arg-Tyr-Leu-Ala-Asp-Leu-Arg-Gln-Arg-Leu-Leu-Glu-Lys-NH2)
|
CG55299
|
2.5 mg
|
300.00
|
|
Peptide
|
Synthetic peptide
|
Eledoisin
|
|
MF: C54H85N13O15S1, MW: 1188.44(pGlu-Pro-Ser-Lys-Asp-Ala-Phe-Ile-Gly-Leu-Met-NH2)
|
CG55392
|
5 mg
|
120.00
|
|
Peptide
|
Synthetic peptide
|
Eledoisin Related Peptide
|
|
MF: C34H58N8O6S1, MW: 706.96(H-Lys-Phe-Ile-Gly-Leu-Met-NH2)
|
CG55248
|
5 mg
|
90.00
|
|
Peptide
|
Synthetic peptide
|
Eledoisin Related Peptide
|
|
MF: C34H58N8O6S1, MW: 706.96(H-Lys-Phe-Ile-Gly-Leu-Met-NH2)
|
CG55248
|
10 mg
|
110.00
|
|
Peptide
|
Synthetic peptide
|
Eledoisin Related Peptide
|
|
MF: C34H58N8O6S1, MW: 706.96(H-Lys-Phe-Ile-Gly-Leu-Met-NH2)
|
CG55248
|
25 mg
|
160.00
|
|
Peptide
|
Synthetic peptide
|
Endomorphin-1
|
|
MF: C34H38N6O5, MW: 610.72(H-Tyr-Pro-Trp-Phe-NH2) |
CG55185
|
5 mg
|
140.00
|
|
Peptide
|
Synthetic peptide
|
Endomorphin-1
|
|
MF: C34H38N6O5, MW: 610.72(H-Tyr-Pro-Trp-Phe-NH2) |
CG55185
|
10 mg
|
200.00
|